Little known but red-hot marijuana growth stock MediPharm Labs Corp (TSXV:LABS) could enjoy further exposure after announcing its application to up-list from the TSX Venture Exchange to the main TSX yesterday, and there’s good reason to anticipate good returns on investment. The company has been one of the hottest cannabis stocks so far in 2019 after reporting two consecutive quarters…
Read More
Many investors may not be aware of it, but over a short time horizon, it tends to be volatility that will dominate the level and direction of investment performance. Yet it’s a much different story when using a longer time horizon, with an investment’s prospects for future growth ultimately proving to be the primary determinant of its chances for long-term…
Read More
It’s that time of year already, and Canopy Growth (TSX:WEED)(NYSE:CGC) stock is set for a potentially turbulent week as the cannabis company gears up to release its fourth-quarter results tomorrow. It seems a good time to recap what analysts will be looking for in tomorrow’s report, which is sure to divide marijuana investors. First, however, let’s look back at last…
Read More
Finding undervalued stocks can be one of the best ways to turn a small investment into huge gains. Many stocks have been getting hammered over the past month, and this has created several buying opportunities for those who are willing to find them. When it comes to pot stocks, things are no different. There are dozens of cannabis stocks trading…
Read More
These past few months have been a rough ride for Aphria (TSX:APHA)(NYSE:APHA) investors. After reaching a peak closing price of $14.21 in February, the stock began sliding later that month, with the downtrend accelerating in April. By May 17, the stock was trading at just $9.19 — a 35% decline from its peak price. The decline in Aphria’s share price comes…
Read More
Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has done a great job of growing its sales in recent quarters. However, recording a positive earnings result has proven to be much more elusive and difficult for the company. When it does post a positive net income figure, it’s usually the result of non-operational items that give the company a boost, which isn’t something investors…
Read More
The cannabis industry is big business, and for companies that can take advantage of its strong growth, the potential could be significant. It’s why we’ve seen retailers and companies from other industries look to get involved and get a piece of the lucrative pie. With the industry still experience a lot of growth, it’s an attractive time for companies to…
Read More
Over the past three years, marijuana has been the biggest success story on the TSX. With stocks like Canopy Growth (TSX:WEED)(NYSE:CGC) up thousands of percentage points since 2015, the marijuana sector has been leading the index in overall gains. If you’d invested $10,000 in Canopy Growth at its IPO and held, you could cash out for $200,000 today — and…
Read More
The edible marijuana market is launching in December, but it may not result in the boom that many are hoping or expecting for. Health Canada unveiled its plans for edibles and like its first launch of cannabis products, there will be some significant restrictions for cannabis companies. Not only will advertising remain very limited, but it will create inefficiencies for…
Read More
Cannabis stocks have encountered choppy conditions in the spring, which should come as no surprise after a hot start to the year. The largest cannabis company in Canada by market cap is Canopy Growth (TSX:WEED)(NYSE:CGC). Shares of Canopy Growth had dropped 10.4% month over month as of close on June 12. The stock was still up 55.8% in 2019 so…
Read More